-
Man Utd can fight for Premier League title in next few years: Amorim
-
Pandya blitz powers India to T20 series win over South Africa
-
Misinformation complicated Brown University shooting probe: police
-
IMF approves $206 mn aid to Sri Lanka after Cyclone Ditwah
-
Stocks advance as markets cheer weak inflation
-
Emery says rising expectations driving red-hot Villa
-
Three killed in Taipei metro attacks, suspect dead
-
Seven Colombian soldiers killed in guerrilla attack: army
-
Amorim takes aim at Man Utd youth stars over 'entitlement'
-
Mercosur meets in Brazil, EU eyes January 12 trade deal
-
US Fed official says no urgency to cut rates, flags distorted data
-
Rome to charge visitors for access to Trevi Fountain
-
Spurs 'not a quick fix' for under-fire Frank
-
Poland president accuses Ukraine of not appreciating war support
-
Stocks advance with focus on central banks, tech
-
Amorim unfazed by 'Free Mainoo' T-shirt ahead of Villa clash
-
PSG penalty hero Safonov ended Intercontinental win with broken hand
-
French court rejects Shein suspension
-
'It's so much fun,' says Vonn as she milks her comeback
-
Moscow intent on pressing on in Ukraine: Putin
-
UN declares famine over in Gaza, says 'situation remains critical'
-
Guardiola 'excited' by Man City future, not pondering exit
-
Czechs name veteran coach Koubek for World Cup play-offs
-
PSG penalty hero Safonov out until next year with broken hand
-
Putin says ball in court of Russia's opponents in Ukraine talks
-
Czech Zabystran upsets Odermatt to claim Val Gardena super-G
-
NGOs fear 'catastrophic impact' of new Israel registration rules
-
US suspends green card lottery after MIT professor, Brown University killings
-
Arsenal in the 'right place' as Arteta marks six years at club
-
Sudan's El-Fasher under the RSF, destroyed and 'full of bodies'
-
From farms to court, climate-hit communities take on big polluters
-
Liverpool have 'moved on' from Salah furore, says upbeat Slot
-
Norway crown princess likely to undergo lung transplant
-
Iraq negotiates new coalition under US pressure
-
France's budget hits snag in setback for embattled PM
-
Putin hails Ukraine gains, threatens more, in annual press conference
-
US suspends green card lottery after Brown, MIT professor shootings
-
Chelsea's Maresca says Man City link '100 percent' speculation
-
Dominant Head moves into Bradman territory with fourth Adelaide ton
-
Arsenal battle to stay top of Christmas charts
-
Mexican low-cost airlines Volaris and Viva agree to merger
-
Border casinos caught in Thailand-Cambodia crossfire
-
Australia's Head slams unbeaten 142 to crush England's Ashes hopes
-
Epstein files due as US confronts long-delayed reckoning
-
'Not our enemy': Rush to rearm sparks backlash in east Germany
-
West Indies 110-0, trail by 465, after Conway's epic 227 for New Zealand
-
Arsonists target Bangladesh newspapers after student leader's death
-
Volatile Oracle shares a proxy for Wall Street's AI jitters
-
Tears at tribute to firefighter killed in Hong Kong blaze
-
Seahawks edge Rams in overtime thriller to seize NFC lead
| SCS | 0.12% | 16.14 | $ | |
| RYCEF | -0.98% | 15.25 | $ | |
| CMSC | 0.02% | 23.295 | $ | |
| RBGPF | 0% | 80.22 | $ | |
| VOD | 0.66% | 12.885 | $ | |
| GSK | 1.16% | 48.855 | $ | |
| NGG | 0.52% | 76.79 | $ | |
| RELX | 0.6% | 40.895 | $ | |
| AZN | 1.24% | 91.75 | $ | |
| RIO | 0.96% | 78.38 | $ | |
| BCE | 0.63% | 22.995 | $ | |
| BCC | -3.75% | 74.89 | $ | |
| BTI | -0.08% | 56.995 | $ | |
| JRI | 0.07% | 13.44 | $ | |
| BP | 1.99% | 33.985 | $ | |
| CMSD | -0.16% | 23.242 | $ |
Bausch Health Announces Results of Special Meeting of Shareholders
LAVAL, QC / ACCESS Newswire / October 9, 2025 / Bausch Health Companies Inc. (the "Company") (NYSE:BHC)(TSX:BHC) today announced the results of the special meeting of shareholders held on October 7, 2025 (the "Shareholders Meeting"). At the Shareholders Meeting, shareholders of the Company approved the ratification, confirmation and approval of the adoption of the Company's Amended and Restated Shareholder Rights Plan Agreement dated April 14, 2025, as amended and restated on August 25, 2025 (the "Rights Plan Agreement"), as described in detail in the Company's Management Proxy Circular and Proxy Statement dated August 27, 2025.
The final vote tabulation for the matter voted on at the Shareholders Meeting will be reported to the U.S. Securities and Exchange Commission on a current report on Form 8-K, and such report will be made available on the Company's SEDAR+ profile, at www.sedarplus.ca, and on the Company's website at www.bauschhealth.com.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the Safe Harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
(877) 281-6642 (toll free) | (908) 569-3692 |
SOURCE: Bausch Health Companies Inc.
View the original press release on ACCESS Newswire
A.Rodriguezv--AMWN